Executive read
A lead can move through education, insurance or benefits, physician selection, financing, and multiple clinical steps. Channel-level last-click reporting cannot describe that sequence.
Four lenses translate the public evidence into the questions a category marketer needs to answer: how demand is created, where conversion happens, where measurement breaks, and what to change.
Education precedes action
Patients may move through clinical education, financing, benefits, physician selection, and partner referrals over a long window.
A lead is far from a completed cycle
Consultation, eligibility, diagnostic work, treatment start, and repeated clinical steps all carry different economic meaning.
Sensitive journeys resist simple retargeting
Privacy expectations and platform restrictions reduce the value of conventional pixel-led audience and last-click approaches.
Use durable, consented journey stitching
Connect education and referral touchpoints to clinical progression without exposing sensitive patient context to activation tools.
Directional conclusions from 1 completed public-source reviews across 6 operators. The remaining company deep dives can change the segment read.
Category evidence
Four findings worth carrying into the operating model
US Fertility provides a strong multi-brand case, while current operator sources define the clinic, laboratory, partner-network, and signature-site boundaries the category needs. Counts below keep their original unit and date; no parent/child brands, stores, clinics, laboratories, beds, or partner sites are silently added together.
The old 295 total counted parent and child
US Fertility includes Shady Grove, so listing both inside one total double-counted the same estate. The parent now reports 120 clinic and laboratory locations.
Local brands persist under centralized services
Prelude says its 90+ North American clinics retain local identities while receiving centralized marketing and operating support.
A consultation is far from a cycle start
Benefit and financial qualification, diagnostics, physician planning, lab capacity, pharmacy, retrieval, transfer, and preservation extend the commercial path.
Sensitive-health rules narrow targeting
Google treats pregnancy and infertility treatment as sensitive health content for personalized advertising. Reporting permission does not create audience permission.
Measurement path
The useful outcome sits beyond the lead
The journey spans physician, laboratory, pharmacy, financing, employer benefits, and sometimes a partner. Clinical outcomes belong in a protected layer rather than an ad-optimization feed.
- 01 education, referral, or employer benefit
- 02 consultation request
- 03 benefit and financial qualification
- 04 attended consult and diagnostics
- 05 treatment plan
- 06 cycle start
- 07 retrieval, transfer, or preservation
- 08 collected revenue and future care
network × patient brand × clinic × physician × lab × service × benefit source
appropriate treatment start and protected longitudinal value
- qualified-consult CAC
- consult show rate
- diagnostic completion
- cycle start
- capacity and collected revenue
Creative evidence
The category becomes legible when the real work is visible
These attributed first-party examples show how operators frame need, trust, access, and outcomes. They are editorial evidence, not a performance ranking.
The treatment journey is expressed through a future family moment
The image communicates the emotional outcome without reducing a long, sensitive care path to a promotional offer.
Inclusive family imagery makes the audience explicit
The creative widens relevance through representation while preserving a calm, trust-first tone appropriate to the category.
A real-family story carries more trust than a funnel claim
Patient-story imagery supplies social proof without implying that one outcome or timeline applies to every treatment journey.
3 of 3 examples shown
AI adoption
Nine workflows: what AI changes, and what it still cannot fix
Fertility has the strongest verified AI adoption in patient navigation and IVF engagement, while acquisition creative, paid-media settings, attribution, and privacy remain far less transparent and more constrained by clinical sensitivity.
This guide reviewed US Fertility, Kindbody, and CCRM evidence through 2026-08-04. US Fertility's Alife rollout is a live clinical and patient-engagement example, not marketing acquisition AI. Kindbody's 2026 AI navigator is a structured pilot, and broad availability is stated for 2027. Platform ad capability is not operator adoption.
Creative production
Rare Maturity basis · Cross-industry proxyNo audited fertility operator publicly disclosed generative-AI campaign production. Google and Meta can generate or transform assets, but operator settings and workflows are not public.
Still manual / non-AITeams still source consented patient stories and imagery, define services and offers, validate clinical claims, and approve representation and tone.
Google documents generative images and text with advertiser review; it publishes no fertility-operator adoption denominator.
Fertility imagery, outcomes, patient stories, and eligibility claims carry exceptional consent, trust, and clinical-risk requirements.
Message and copy generation
Rare Maturity basis · Improvado hypothesisNo audited fertility operator disclosed AI-written acquisition or clinical copy. Public content and patient stories remain brand- and clinician-governed.
Still manual / non-AISuccess-rate wording, treatment fit, cost and insurance, donor or surrogacy context, local availability, and clinical review remain human work.
The network publishes education and patient journeys across distinct brands; no public source attributes this content to AI generation.
Unrestricted generation can invent outcome, eligibility, coverage, timing, or treatment claims during a high-stakes decision.
Paid-media optimization
Widespread Maturity basis · Cross-industry proxyGoogle and Meta automate bids, delivery, audiences, placements, and creative selection. Fertility brands advertise on these platforms, but the audited operators' AI campaign settings are not public.
Still manual / non-AITeams still define geography, service, budget, brand, conversion, exclusions, contextual intent, and whether a downstream signal is permitted for activation.
Google documents AI optimization across campaign functions; this proves platform capability, not fertility-operator activation.
Pregnancy and infertility are sensitive interests for personalized advertising, and fertility promotion is restricted in some locations.
SEO and GEO
Emerging Maturity basis · Verified industry evidenceIVF Florida currently loads BrightEdge Autopilot, providing AI-assisted technical and internal-link optimization. No network-wide US Fertility GEO program was verified.
Still manual / non-AIClinicians and marketers still own treatment accuracy, provider and location facts, content freshness, source quality, and final publication.
BrightEdge Autopilot was present in live IVF Florida source when checked 2026-08-04; one brand implementation is not a category rate.
AI search rewards clear answers, but automated clinical content can scale stale evidence, weak sourcing, or unsupported outcome claims.
UTM, attribution, and data QA
Rare Maturity basis · Improvado hypothesisNo audited fertility operator disclosed AI attribution QA. US Fertility's public estate shows multiple brand, analytics, form, and agency measurement surfaces instead.
Still manual / non-AITeams maintain brand and location crosswalks, form and call joins, consent state, consult status, agency reconciliation, and revenue definitions.
Public site evidence shows distinct tracking and conversion implementations across patient brands; it does not expose a shared AI QA layer.
A fertility journey can contain sensitive health context, and AI cannot repair missing identifiers or create permission to join them.
Call analysis
Rare Maturity basis · Improvado hypothesisNo named AI call-analysis deployment was verified for the audited fertility operators, and no major call-intelligence tag was visible in the scanned US Fertility sources.
Still manual / non-AIIntake teams still answer treatment, benefits, cost, urgency, donor, surrogacy, and scheduling questions and document disposition.
Invoca documents healthcare AI call classification and BAA-supported workflows; no audited fertility operator use was found.
Calls reveal intimate health and family-building context, so recording, transcription, model use, retention, and activation require strict governance.
Lead routing and CRM
Emerging Maturity basis · Operator exampleKindbody announced an AI care navigator for benefit activation, intake, triage, scheduling, and provider matching in a structured 2026 employer-member pilot.
Still manual / non-AIHuman navigators and clinicians still handle benefit exceptions, complex treatment fit, urgency, emotional support, and clinical escalation.
Kindbody's February 2026 announcement defines a limited 2026 pilot and broad availability in 2027; it is not a network-wide current adoption claim.
Benefit eligibility, provider fit, geography, treatment urgency, and clinical nuance are not safely resolved from marketing context alone.
Scheduling and patient engagement
Emerging Maturity basis · Operator exampleUS Fertility deploys Alife's AI-driven embryo reporting nationwide for direct patient engagement. Kindbody separately announced AI navigation and scheduling in its 2026 pilot.
Still manual / non-AIEmbryologists, clinicians, care navigators, and staff still interpret results, counsel patients, manage exceptions, and own treatment decisions.
The March 2025 operator announcement describes nationwide AI-supported embryo reports and reduced manual documentation; this is patient engagement, not acquisition AI.
Clinical outputs need validation and explanation, while scheduling and benefits workflows still require current eligibility, availability, and escalation data.
Compliance and privacy
Rare Maturity basis · Improvado hypothesisNo audited fertility operator disclosed AI as its compliance authority. AI can assist policy checks, redaction, and data-flow review, but it cannot create consent or override sensitive-ad restrictions.
Still manual / non-AIEntity scope, consent, BAAs, fertility-ad eligibility, state and country rules, minimum-necessary use, patient communications, and incident ownership remain human decisions.
Google classifies pregnancy and infertility as sensitive for personalized targeting and restricts fertility promotion in specified locations.
Fertility data is highly sensitive, and permission to report aggregate performance is not permission to target or personalize an individual.
Operator map
Where fertility & ivf operators sit
Highlighted companies have enough dated public evidence for both directional scores. The full cohort stays in the background for market context.
Where public demand intensity meets marketing-operations centralization
Directional scores synthesize dated public ad-library, website, tag-layer, and operating-model evidence. They are not spend, revenue, or vendor-performance scores, and not published rubric composites; positions are directional synthesis.
- Aspen Dental: paid demand 70 out of 100; marketing operations centralization 88 out of 100.
- Heartland Dental: paid demand 45 out of 100; marketing operations centralization 22 out of 100.
- PDS Health: paid demand 72 out of 100; marketing operations centralization 92 out of 100.
- SALT Dental Partners: paid demand 22 out of 100; marketing operations centralization 15 out of 100.
- Smile Brands: paid demand 68 out of 100; marketing operations centralization 20 out of 100.
- Smile Doctors: paid demand 72 out of 100; marketing operations centralization 62 out of 100.
- Sonrava Health: paid demand 68 out of 100; marketing operations centralization 34 out of 100.
- Forefront Dermatology: paid demand 26 out of 100; marketing operations centralization 86 out of 100.
- QualDerm Partners: paid demand 30 out of 100; marketing operations centralization 58 out of 100.
- US Fertility: paid demand 55 out of 100; marketing operations centralization 16 out of 100.
- LaserAway: paid demand 78 out of 100; marketing operations centralization 70 out of 100.
- Milan Laser: paid demand 90 out of 100; marketing operations centralization 74 out of 100.
- SEV Laser: paid demand 82 out of 100; marketing operations centralization 72 out of 100.
- 4Ever Young: paid demand 76 out of 100; marketing operations centralization 55 out of 100.
- SkinSpirit: paid demand 68 out of 100; marketing operations centralization 84 out of 100.
- VIO Med Spa: paid demand 72 out of 100; marketing operations centralization 55 out of 100.
- OVME: paid demand 63 out of 100; marketing operations centralization 80 out of 100.
- Ever/Body: paid demand 55 out of 100; marketing operations centralization 78 out of 100.
- Beltone: paid demand 30 out of 100; marketing operations centralization 12 out of 100.
- HearingLife: paid demand 30 out of 100; marketing operations centralization 84 out of 100.
- Miracle-Ear: paid demand 40 out of 100; marketing operations centralization 45 out of 100.
- The Joint: paid demand 84 out of 100; marketing operations centralization 52 out of 100.
- ATI Physical Therapy: paid demand 30 out of 100; marketing operations centralization 70 out of 100.
- NovaCare: paid demand 10 out of 100; marketing operations centralization 74 out of 100.
- Select Physical Therapy: paid demand 12 out of 100; marketing operations centralization 66 out of 100.
- U.S. Physical Therapy: paid demand 10 out of 100; marketing operations centralization 12 out of 100.
- Upstream Rehabilitation: paid demand 14 out of 100; marketing operations centralization 38 out of 100.
- American Family Care: paid demand 62 out of 100; marketing operations centralization 15 out of 100.
- CityMD: paid demand 40 out of 100; marketing operations centralization 80 out of 100.
- Concentra: paid demand 6 out of 100; marketing operations centralization 72 out of 100.
- USA Vein Clinics: paid demand 64 out of 100; marketing operations centralization 84 out of 100.
- Banfield: paid demand 52 out of 100; marketing operations centralization 76 out of 100.
- Thrive Pet Healthcare: paid demand 58 out of 100; marketing operations centralization 30 out of 100.
- VCA Animal Hospitals: paid demand 50 out of 100; marketing operations centralization 72 out of 100.
- VetCor: paid demand 18 out of 100; marketing operations centralization 38 out of 100.
- MyEyeDr: paid demand 85 out of 100; marketing operations centralization 85 out of 100.
- National Vision: paid demand 45 out of 100; marketing operations centralization 68 out of 100.
Footprints
Largest known operator footprints
Location counts come from the dated research registry and first-party public directories. They are shown to explain operating scale, not to rank quality or performance.
Implications
The measurement design follows the operating model
Model location explicitly
Media, calls, forms, appointments, and revenue need one durable facility identifier.
Separate collection from activation
Privacy-safe collection does not by itself create a governed reporting or activation layer.
Preserve local context
National rollups stay useful only when teams can drill into brand, market, service, and location.
This section describes data-design implications from the research. It is not a claim that every operator has the same stack, privacy obligations, or level of centralization.
Method
A dated public-source edition
The segment inherits the parent report method: location directories, sitemaps, booking paths, public web tags, ad transparency libraries, ownership announcements, and public operating-model evidence.
Private CRM history, sales calls, contacts, customer data, internal scoring, and recommendations are excluded. Technology detection means a signal was visible on a reviewed surface; it does not prove enterprise-wide deployment.
- Clinic, lab, partner-network, brand, and parent-system counts are not interchangeable.
- One complete company audit cannot establish an industry implementation rate.
- Protected clinical outcomes should not be published or exported to advertising platforms as optimization events.